AstraZeneca Plc said on Wednesday an advisory committee of the U.S. Centers for Disease Control and Prevention recommended the use of its FluMist Quadrivalent vaccine in the upcoming flu season, reversing its earlier position.
- Study seeks to end antidepressant debate: the drugs do work
- Philip Morris may have breached Lithuania's advertising rules with new smoking device
- Venezuelans report big weight losses in 2017 as hunger hits
- U.S. FDA says recalls, destroys certain kratom-containing dietary products
- Novo Nordisk gets nod from U.S. drug purchaser for new diabetes hope
(Reuters Health) - Cigarettes are not the only type of tobacco products that can lead to premature death or fatalities from smoking-related cancers, a U.S. study confirms.
(Reuters Health) - The amount of foods containing sugars or other carbohydrates that a woman eats has nothing to do with the likelihood she will start experiencing premenstrual syndrome (PMS), researchers say.
Nearly 70 percent of children with potentially fatal acute Graft Versus Host Disease responded to treatment with an experimental stem cell therapy from Mesoblast Ltd, meeting the primary goal of a late-stage U.S. trial, the Australian company announced on Wednesday.
(Reuters Health) - The expensive anti-clotting drug Xarelto is no better than common aspirin when it comes to preventing painful and potentially-deadly clots in people who have just had total hip or total knee replacement surgery, according to a new Canadian study.